Grupo Ferrer Internacional S.A. - Strategy, SWOT and Corporate Finance Report
Summary
Grupo Ferrer Internacional S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Grupo Ferrer Internacional S.A. (Ferrer or 'the company') is a provider of pharmaceuticals and chemicals. The company manufactures and distributes various pharmaceutical products for various therapeutic areas including gastrointestinal, musculoskeletal system, pain management, cardiovascular, central nervous system, oncology, dermatology, pediatrics and the respiratory system. It also provides diagnostics services. The company offers its products under Adasuve, Nucleo, Keltican, Cleviprex, Nubit, Somazina, Dubine, and Dislep brand names. Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermo-cosmetics, sunscreens, food supplements, infant nutrition products, over-the-counter medicines, insect repellants and anti-lice products. The company operates production facilities in Spain and the US. The company is headquartered in Barcelona, Spain.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook